Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy
Jenniffer Linares, Juan A. Marín‐Jiménez, Jordi Badia-Ramentol, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Paris Jabeen Asif, Ciro Longobardi, Michael Hahne, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4720-4720
Open Access | Times Cited: 174
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
Gürcan Günaydın
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 142
Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications
Karim Rihawi, Angela Dalia Ricci, Alessandro Rizzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3805-3805
Open Access | Times Cited: 132
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
Ralf‐Peter Czekay, Dong‐Joo Cheon, Rohan Samarakoon, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1231-1231
Open Access | Times Cited: 79
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 68
TME-Related Biomimetic Strategies Against Cancer
Cheng Peng, Yilin Xu, Jing Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 109-135
Open Access | Times Cited: 30
From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy
Sikiru O. Imodoye, Kamoru A. Adedokun, Ibrahim O. Bello
Histochemistry and Cell Biology (2024) Vol. 161, Iss. 4, pp. 299-323
Closed Access | Times Cited: 16
The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
Paul Manoukian, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 61
Targeting of the tumor immune microenvironment by metformin
Zihong Wu, Caidie Zhang, Masoud Najafi
Journal of Cell Communication and Signaling (2021) Vol. 16, Iss. 3, pp. 333-348
Open Access | Times Cited: 56
Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer
Cemre Ucaryilmaz Metin, Gülnihal Özcan
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 54
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
Elisa Rivas, Jenniffer Linares, Melissa Zwick, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
A comprehensive review of pancreatic cancer and its therapeutic challenges
Shan Jiang, Johan Bourghardt Fagman, Yunyun Ma, et al.
Aging (2022) Vol. 14, Iss. 18, pp. 7635-7649
Open Access | Times Cited: 45
Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6
Young Eun Lee, Ga-Yeon Go, Eun‐Young Koh, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006130-e006130
Open Access | Times Cited: 31
Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
Nisa Chuangchot, Pranisa Jamjuntra, Supaporn Yangngam, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 26
Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer
Mingjie Wang, Wenxiang Xue, Hanghang Yuan, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2823-2849
Open Access | Times Cited: 10
IFNγ and TNFα drive an inflammatory secretion profile in cancer‐associated fibroblasts from human non‐small cell lung cancer
Lilian Koppensteiner, Layla Mathieson, LYNNE NEILSON, et al.
FEBS Letters (2025)
Open Access | Times Cited: 1
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing
Alice Perucca, Andrea Gómez Llonín, Oriol Mañé Benach, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity
Linda Ziani, Stéphanie Buart, Salem Chouaı̈b, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 55
Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy
Ming Jia, Dan Zhang, Chunxiang Zhang, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Differentiation of the tumor microenvironment: are CAFs the Organizer?
Marina Kochetkova, Michael S. Samuel
Trends in Cell Biology (2021) Vol. 32, Iss. 4, pp. 285-294
Closed Access | Times Cited: 48
Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway
Rajalaxmi Pradhan, Subarno Paul, Biswajit Das, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 113, pp. 109257-109257
Closed Access | Times Cited: 32
Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells
Katayoon Pakravan, Majid Mossahebi‐Mohammadi, Mohammad H. Ghazimoradi, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 29
Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients
Hualin Chen, Wenjie Yang, Xiaoqiang Xue, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15970-15970
Open Access | Times Cited: 28
Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe
Elmira Roshani Asl, Davoud Rostamzadeh, Pascal H. G. Duijf, et al.
Life Sciences (2023) Vol. 315, pp. 121361-121361
Closed Access | Times Cited: 19
Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
Deepshikha Mishra, Debabrata Banerjee
Cells (2023) Vol. 12, Iss. 4, pp. 628-628
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top